
Shruti Niranjan Tapiawala
About Shruti Niranjan Tapiawala
Data last updated:
Shruti Niranjan Tapiawala is a Director at Advanced Transplant Diagnostics And Immunogenetics Private Limited (since 2019), Director at Atdi Lab Private Limited (since 2020) and Director at Advanced Renal Replacement Therapies Center Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Healthcare and Non-Profit Organizations. The 3 current companies with reported revenue have a combined latest revenue of ₹5.46 Cr; the largest is Advanced Transplant Diagnostics And Immunogenetics Private Limited at ₹2.72 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Sep 2019 | 2019 | ₹2.72 Cr (FY 2025) | Active | |
| Director | 04 Dec 2020 | 2020 | ₹2.09 Cr (FY 2025) | Active | |
| Director | 25 Mar 2023 | 2023 | ₹65 Lakh (FY 2025) | Active | |
| Director | 24 May 2024 | 2024 | Active |
Board colleagues of Shruti Niranjan Tapiawala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bharat Vallabhdas Shah | 02365426 | Advanced Transplant Diagnostics And Immunogenetics Private Limited , Atdi Lab Private Limited and 2 more | Director |
| Hepal Mihir Vora | 08717027 | Advanced Transplant Diagnostics And Immunogenetics Private Limited , Atdi Lab Private Limited and 1 more | Director |
| Prashant Jayendrasingh Rajput | 08751334 | Advanced Transplant Diagnostics And Immunogenetics Private Limited , Atdi Lab Private Limited and 2 more | Director |
| Zaheer Aminmohamed Virani | 08717035 | Advanced Transplant Diagnostics And Immunogenetics Private Limited , Atdi Lab Private Limited and 2 more | Director |
| Ishan Kishor Parekh | 10088234 | Advanced Renal Replacement Therapies Center Private Limited | Director |
| Kamal Chokshi Chandrakant | 02391241 | Advanced Renal Replacement Therapies Center Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shruti Niranjan Tapiawala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shruti Niranjan Tapiawala
Shruti Niranjan Tapiawala currently holds 4 directorships: Advanced Transplant Diagnostics And Immunogenetics Private Limited (Director, since 09 Sep 2019, revenue ₹2.72 Cr (FY 2025)); Atdi Lab Private Limited (Director, since 04 Dec 2020, revenue ₹2.09 Cr (FY 2025)); Advanced Renal Replacement Therapies Center Private Limited (Director, since 25 Mar 2023, revenue ₹65 Lakh (FY 2025)); Atdi Sambhaji Nagar Lab Private Limited (Director, since 24 May 2024).
Shruti Niranjan Tapiawala was first appointed on 09 Sep 2019 as Director at Advanced Transplant Diagnostics And Immunogenetics Private Limited. The most recent appointment on record is 24 May 2024 at Atdi Sambhaji Nagar Lab Private Limited.
The 3 current companies of Shruti Niranjan Tapiawala that report revenue have a combined latest revenue of ₹5.46 Cr: Advanced Transplant Diagnostics And Immunogenetics Private Limited ₹2.72 Cr (FY 2025); Atdi Lab Private Limited ₹2.09 Cr (FY 2025); Advanced Renal Replacement Therapies Center Private Limited ₹65 Lakh (FY 2025).
The current boards of Shruti Niranjan Tapiawala's companies include Bharat Vallabhdas Shah (Advanced Transplant Diagnostics And Immunogenetics Private Limited), Hepal Mihir Vora (Advanced Transplant Diagnostics And Immunogenetics Private Limited), Prashant Jayendrasingh Rajput (Advanced Transplant Diagnostics And Immunogenetics Private Limited), Zaheer Aminmohamed Virani (Advanced Transplant Diagnostics And Immunogenetics Private Limited), Ishan Kishor Parekh (Advanced Renal Replacement Therapies Center Private Limited), Kamal Chokshi Chandrakant (Advanced Renal Replacement Therapies Center Private Limited).